Åslaug Helland at University of Oslo - Research Interests, Publications & Academic Profile

Åslaug Helland

Professor

University of Oslo

Norway

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Turkish students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Biostatistics

80%

Immunology

40%

Cancer Biology

100%

Oncology

90%

Precision Medicine

60%

Prognostic Biomarker

40%

Cancer Therapy

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles19

Multi‐omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma

Article Link

Year:

2024

PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe

Article Link

Year:

2024

Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 – merging clinical research and standard healthcare

Article Link

Year:

2024

A federated learning system for precision oncology in Europe: DigiONE

Article Link

Year:

2024

UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial

Article Link

Year:

2024

Modified study designs to expand treatment options in personalised oncology: a multistakeholder view

Article Link

Year:

2023

Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer

Article Link

Year:

2023

Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy

Article Link

Year:

2023

Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial

Article Link

Year:

2023

Serum concentrations of amino acids and tryptophan metabolites are affected by consumption of a light breakfast: a clinical intervention study in adults with overweight or obesity

Article Link

Year:

2023

Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway

Article Link

Year:

2022

Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway

Article Link

Year:

2022

Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome

Article Link

Year:

2022

Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials.

Article Link

Year:

2022

A national precision cancer medicine implementation initiative for Norway.

Article Link

Year:

2022

Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma.

Article Link

Year:

2022

Serum RNAs can predict lung cancer up to 10 years prior to diagnosis.

Article Link

Year:

2022

Epigenome-wide three-way interaction study identifies a complex pattern between TRIM27, KIAA0226, and smoking associated with overall survival of early-stage NSCLC.

Article Link

Year:

2022

Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer

Article Link

Year:

2022

Collaborators8

Verena Zuber

Lecturer in Biostatistics

Imperial College London

UNITED KINGDOM

Rakel Brendsdal Forthun

Haukeland University Hospital

NORWAY

Kjetil Tasken

Professor

University of Oslo

NORWAY

Thomas Fleischer

NORWAY

Christophe Le Tourneau

Head of Early Phase Clinical Trials

Institut Curie

FRANCE

Simone Stensgaard

Aarhus University

DENMARK

Katarina Steen Carlsson

SWEDEN

Eivind Hovig

Professor/ Head, Center of Bioinformatics

University of Oslo

NORWAY

How do Turkish students reach out?

Meet Kite AI

Åslaug Helland

Professor

How do Turkish students reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles19

Multi‐omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma

PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe

Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 – merging clinical research and standard healthcare

A federated learning system for precision oncology in Europe: DigiONE

UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial

Modified study designs to expand treatment options in personalised oncology: a multistakeholder view

Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer

Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy

Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial

Serum concentrations of amino acids and tryptophan metabolites are affected by consumption of a light breakfast: a clinical intervention study in adults with overweight or obesity

Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway

Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway

Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome

Osimertinib in non-small cell lung cancer with uncommon <i>EGFR</i>-mutations: a <i>post-hoc</i> subgroup analysis with pooled data from two phase II clinical trials.

A national precision cancer medicine implementation initiative for Norway.

Prognostic Significance of the Loss of Heterozygosity of <i>KRAS</i> in Early-Stage Lung Adenocarcinoma.

Serum RNAs can predict lung cancer up to 10 years prior to diagnosis.

Epigenome-wide three-way interaction study identifies a complex pattern between TRIM27, KIAA0226, and smoking associated with overall survival of early-stage NSCLC.

Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer

Collaborators8

Verena Zuber

Rakel Brendsdal Forthun

Kjetil Tasken

Thomas Fleischer

Christophe Le Tourneau

Simone Stensgaard

Katarina Steen Carlsson

Eivind Hovig

How do Turkish students reach out?